# DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

> **NCT05788835** · NA · RECRUITING · sponsor: **Xuhua Duan** · enrollment: 220 (estimated)

## Conditions studied

- HCC

## Interventions

- **PROCEDURE:** DEB-TACE and HAIC
- **PROCEDURE:** DEB-TACE

## Key facts

- **NCT ID:** NCT05788835
- **Lead sponsor:** Xuhua Duan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-07
- **Primary completion:** 2024-06-07
- **Final completion:** 2026-06-30
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05788835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05788835, "DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05788835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*